Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-19-032042
Filing Date
2019-11-06
Accepted
2019-11-06 16:28:47
Documents
2
Period of Report
2019-11-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 12068
2 POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY doc1.txt EX-24 3028
  Complete submission text file 0001127602-19-032042.txt   16440
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 7575 WEST 103RD AVENUE SUITE 102 WESTMINSTER CO 80021
Business Address
Dickinson Andrew D (Reporting) CIK: 0001310204 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19731 | Film No.: 191196725